{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01236",
      "entity_text" : "prolactin",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:681",
      "entity_text" : "dopamine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Hyperprolactinemia, which accounts for up to 5% of cases of secondary hypogonadism, can result from a prolactin secreting pituitary adenoma (prolactinoma), pressure on the pituitary stalk by any pituitary lesion (interrupting the normal dopamine inhibition of prolactin secretion), medications which affect prolactin secretion (e.g., risperidone, metoclopramide), hypothyroidism, and chronic renal failure.",
  "reading_complete" : "2020-08-04T13:48:19Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T13:47:05Z",
  "trigger" : "inhibition",
  "evidence" : [ "dopamine inhibition of prolactin" ],
  "pmc_id" : "5182242",
  "score" : 0
}